Why China is Leveraging Pharma Factories to Establish Its Future Food Leadership
China is repurposing its existing pharmaceutical and fermentation manufacturing infrastructure to produce alternative proteins. This transition is driven by a…
From cells to real meat
China is repurposing its existing pharmaceutical and fermentation manufacturing infrastructure to produce alternative proteins. This transition is driven by a…
Investors at recent World Agri-Tech and Future Food-Tech conferences conveyed a clear message: startups must now solve real problems for…
Agrifoodtech investors predict 2026 will be a challenging year, marked by tariff uncertainty, extreme weather, and geopolitical conflicts, potentially surpassing…
The alternative protein market is diversifying beyond its initial plant-based focus, which has seen sales flatten. Emerging technologies include fungi…
San Diego-based BlueNalu has secured approximately US$11 million in an entirely insider-led funding round, consisting of cash and stock proceeds…
China’s alternative protein sector experienced significant growth and evolution in 2025, driven by strong government support, including investment in innovation…
Meatly, a supplier of lab-grown chicken cells for pet food, is preparing for significant expansion within the next three to…
European consumers are hesitant to adopt food technology due to a preference for traditional, natural foods and a general distrust…
A new report by the EIT Food agency’s Consumer Observatory indicates that while Europeans are generally receptive to meat alternatives,…
FlyBlast, a Belgian startup that used genetically engineered black soldier flies to produce insulin and other proteins, has filed for…